Reperfusion of the infarct-related coronary artery limits left ventricular expansion beyond myocardial salvage
- PMID: 1575127
- DOI: 10.1016/0002-8703(92)91016-t
Reperfusion of the infarct-related coronary artery limits left ventricular expansion beyond myocardial salvage
Abstract
Previous echocardiographic data from the Gruppo Italiano per lo Studio della Streptochinasi nell' Infarto Miocardico (GISSI 1) trial suggest that the relation between left ventricular end-systolic volume and infarct size could be altered by thrombolysis, which would exert a restraining effect on end-systolic volume beyond its reducing effect on infarct size. Thus in 63 patients with one-vessel disease and a recent anterior myocardial infarction, we tested at angiography (1) if perfusion of the anterior descending coronary artery exerts any restraining effect on end-systolic volume above and beyond infarct size reduction and (2) if ejection fraction reflects such an additional, beneficial difference in the ventricular remodeling process. End-systolic volume was calculated using the Dodge method and the right anterior oblique projection, while infarct size was quantified according to the number of ventricular radii whose percent shortening fell below the mean -2 SD of a group of normal individuals. Patients were then divided into two groups according to the perfusion status of the vessel using Thrombolysis in Myocardial infarction (TIMI) criteria (TIMI grade 0 to 1: nonperfused vessel, 27 patients; TIMI grade 2 to 3: perfused vessel, 36 patients). For both groups there was a significant linear relation (p less than 0.001) between end-systolic volume and infarct size; as in our echocardiographic data, the regression lines relating volume to infarct size showed a different slope in the two populations so that, for large and matched infarcts, end-systolic volume was smaller in patients with a perfused vessel (p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Effect of streptokinase on left ventricular modeling and function after myocardial infarction: the GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico) Trial.J Am Coll Cardiol. 1989 Nov 1;14(5):1149-58. doi: 10.1016/0735-1097(89)90409-9. J Am Coll Cardiol. 1989. PMID: 2681320 Clinical Trial.
-
Independent impact of thrombolytic therapy and vessel patency on left ventricular dilation after myocardial infarction. Serial echocardiographic follow-up.Circulation. 1994 Aug;90(2):800-7. doi: 10.1161/01.cir.90.2.800. Circulation. 1994. PMID: 8044951
-
Importance of early and complete reperfusion to achieve myocardial salvage after thrombolysis in acute myocardial infarction.Am J Cardiol. 1992 Dec 1;70(18):1391-6. doi: 10.1016/0002-9149(92)90287-9. Am J Cardiol. 1992. PMID: 1442606
-
[Effect of thrombolytic agents on infarct size and left ventricle systolic function in myocardial infarction].Arch Mal Coeur Vaiss. 1990 Feb;83 Spec No 1:31-6. Arch Mal Coeur Vaiss. 1990. PMID: 2108644 Review. French.
-
Effects on infarct size and left ventricular function of early intravenous injection of anistreplase in acute myocardial infarction. The APSIM Study Investigators.Clin Cardiol. 1990 Mar;Suppl 5:V39-44; discussion V67-72. doi: 10.1002/clc.4960131310. Clin Cardiol. 1990. PMID: 2182240 Review.
Cited by
-
Predictors of early and late ventricular remodeling after acute myocardial infarction.Clin Cardiol. 1999 Sep;22(9):581-6. doi: 10.1002/clc.4960220908. Clin Cardiol. 1999. PMID: 10486697 Free PMC article.
-
Alteplase. A reappraisal of its pharmacological properties and therapeutic use in acute myocardial infarction.Drugs. 1995 Jul;50(1):102-36. doi: 10.2165/00003495-199550010-00008. Drugs. 1995. PMID: 7588083 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical